212 related articles for article (PubMed ID: 15688837)
1. [Guideline on 'non-small cell lung carcinoma; staging and treatment'].
van Meerbeeck JP; Koning CC; Tjan-Heijnen VC; Boekema AG; Kaandorp CJ; Burgers JS
Ned Tijdschr Geneeskd; 2005 Jan; 149(2):72-7. PubMed ID: 15688837
[TBL] [Abstract][Full Text] [Related]
2. [Multimodal treatment of non small cell lung cancer].
Stoelben E; Digel W; Henke M; Passlick B
Zentralbl Chir; 2006 Apr; 131(2):110-4. PubMed ID: 16612776
[TBL] [Abstract][Full Text] [Related]
3. Treatment of locally advanced non-small cell lung cancer.
Fidler MJ; Kim AW; Zusag T; Bonomi P
Clin Adv Hematol Oncol; 2009 Jul; 7(7):455-64, 479-80. PubMed ID: 19701153
[TBL] [Abstract][Full Text] [Related]
4. Poor correspondence between clinical and pathologic staging in stage 1 non-small cell lung cancer: results from CALGB 9761, a prospective trial.
D'Cunha J; Herndon JE; Herzan DL; Patterson GA; Kohman LJ; Harpole DH; Kernstine KH; Kern JA; Green MR; Maddaus MA; Kratzke RA;
Lung Cancer; 2005 May; 48(2):241-6. PubMed ID: 15829324
[TBL] [Abstract][Full Text] [Related]
5. Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature?
Langer CJ; Moughan J; Movsas B; Komaki R; Ettinger D; Owen J; Wilson JF
Lung Cancer; 2005 Apr; 48(1):93-102. PubMed ID: 15777975
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of patients with stage III non-small cell lung cancer: concurrent high-dose chemotherapy and radiotherapy].
El Sharouni SY; Aerts JG; Senan S; De Ruysscher DK; Groen HJ; Paul MA; Smit EF; Vonk EJ; Verhagen AF; Schramel FM
Ned Tijdschr Geneeskd; 2008 Dec; 152(50):2714-7. PubMed ID: 19192584
[TBL] [Abstract][Full Text] [Related]
7. ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer.
De Leyn P; Lardinois D; Van Schil PE; Rami-Porta R; Passlick B; Zielinski M; Waller DA; Lerut T; Weder W
Eur J Cardiothorac Surg; 2007 Jul; 32(1):1-8. PubMed ID: 17448671
[TBL] [Abstract][Full Text] [Related]
8. [The role of neoadjuvant therapy in the treatment of locally advanced, stage III non-small-cell lung cancer].
Balikó Z; Sárosi V
Magy Onkol; 2005; 49(2):161-8. PubMed ID: 16249813
[TBL] [Abstract][Full Text] [Related]
9. FDG-PET imaging for lymph node staging and pathologic tumor response after neoadjuvant treatment of non-small cell lung cancer.
Ohtsuka T; Nomori H; Ebihara A; Watanabe K; Kaji M; Naruke T; Suemasu K; Uno K
Ann Thorac Cardiovasc Surg; 2006 Apr; 12(2):89-94. PubMed ID: 16702929
[TBL] [Abstract][Full Text] [Related]
10. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
11. [Surgery and chemoradiation in stage IIIA non-small cell lung cancer].
Hennequin C; Girard N; Mornex F
Cancer Radiother; 2006 Nov; 10(6-7):477-83. PubMed ID: 17046307
[TBL] [Abstract][Full Text] [Related]
12. Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response.
Pourel N; Santelmo N; Naafa N; Serre A; Hilgers W; Mineur L; Molinari N; Reboul F
Eur J Cardiothorac Surg; 2008 May; 33(5):829-36. PubMed ID: 18367406
[TBL] [Abstract][Full Text] [Related]
13. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M
Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
[TBL] [Abstract][Full Text] [Related]
14. Patient subsets benefiting from adjuvant therapy following surgical resection of non-small cell lung cancer.
Johnson BE; Rabin MS
Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5022s-5026s. PubMed ID: 16000607
[TBL] [Abstract][Full Text] [Related]
15. Sequencing chemotherapy, radiotherapy and surgery in combined modality treatment of stage III nonsmall cell lung cancer.
Maas KW; El Sharouni SY; Smit EF; Schramel FM
Curr Opin Pulm Med; 2007 Jul; 13(4):297-304. PubMed ID: 17534176
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic management of non-small-cell lung carcinoma (NSCLC) of stage III A].
Mornex F
Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S29-32. PubMed ID: 11924239
[No Abstract] [Full Text] [Related]
17. [Guide line for the treatment of stage I and stage II non small cell lung cancer].
Kobayashi K
Nihon Geka Gakkai Zasshi; 2004 Jul; 105(7):392-403. PubMed ID: 15303438
[TBL] [Abstract][Full Text] [Related]
18. Intraoperative (125)I Vicryl mesh brachytherapy after sublobar resection for high-risk stage I non-small cell lung cancer.
Voynov G; Heron DE; Lin CJ; Burton S; Chen A; Quinn A; Santos R; Colonias A; Landreneau RJ
Brachytherapy; 2005; 4(4):278-85. PubMed ID: 16344258
[TBL] [Abstract][Full Text] [Related]
19. Comparison of neoadjuvant cisplatin-based chemotherapy versus radiochemotherapy followed by resection for stage III (N2) NSCLC.
Pezzetta E; Stupp R; Zouhair A; Guillou L; Taffé P; von Briel C; Krueger T; Ris HB
Eur J Cardiothorac Surg; 2005 Jun; 27(6):1092-8. PubMed ID: 15896624
[TBL] [Abstract][Full Text] [Related]
20. Comparison of curative and palliative radiotherapy efficacy in unresectable advanced non-small cell lung cancer patients with or without metastasis.
Unlu I; Diniz G; Komurcuoglu B; Gayaf M; Gokce T; Karadogan I; Akcay C
Saudi Med J; 2006 Jun; 27(6):849-53. PubMed ID: 16758049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
